Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Microdermis launches Provodine in award-winning packaging

Ampac’s seven-layer laminate provides package integrity, barrier, portability, and dispensing functionality for this next-generation infection control product.

Next-generation infection control product Provodine cream includes aggressive chemical compounds that were addressed by an award-winning seven-layer flexible packaging structure for the product’s 3-mL packette shown here.
Next-generation infection control product Provodine cream includes aggressive chemical compounds that were addressed by an award-winning seven-layer flexible packaging structure for the product’s 3-mL packette shown here.

A laminated flexible film structure from Ampac proved essential in helping lifesciences company Microdermis Corp. launch its flagship product Provodine®, an infection-control product to be initially targeted to the U.S. military.

The proprietary structure earned a 2015 AmeriStar Award in the Drug & Pharmaceutical category.

Princeton, NJ-based Microdermis Corp. is a lifesciences company that focuses on the development of novel products based on its patented Amidermal® technology.

Harry Corless, VP of Technical Operations for Microdermis, notes, “Provodine is a cream targeted initially only in the U.S., but soon globally starting in South America. Beginning with the U.S. military, it will be sold into the professional market, to hospitals, clinics, and long-term care facilities.”

Provodine is sold presently in 3-mL packettes/sachets, 4-oz bottles, and 16-oz bottles with pumps, with additional SKUs planned for next year. For this article, the focus is on the product’s fast-growing packettes.

Microdermis refers to the product as a next-generation professional antiseptic that meets or exceeds FDA requirements for use as a surgical scrub, pre-operative skin preparation, healthcare personnel hand wash, and first aid antiseptic.

Provodine uses Microdermis’ Amidermal technology for enhanced kill strength of dangerous microbes. Provodine has been tested against most category 1 (deadly/weaponized/no known cures) pathogens and kills them all within 30 seconds of exposure time, even after 12 hours of dry time on exposed skin.

There are currently no known resistant strains to Provodine, useful for deployment in challenging environments with an unknown mix of infection sources, such as in military field hospitals, and with globally deployed NGO (non-governmental organization) personnel.

Provodine uses Povidone-Iodine and contains a proprietary blend of skin moisturizers and humectants that nourish and rebuild the skin, eliminating dryness and cracking, which are not only uncomfortable, but also create portals for microbes.

Corless says, “Provodine has a broad spectrum of kill, provides increased longevity of protection, and is more gentle to the skin than other competitive products in the market today.”

Considerable packaging requirements

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO